Plain-English translation of NCT07489911 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →This study is looking at how well Trimbow (a single inhaler that combines three different asthma medicines) helps people who have asthma that isn't well controlled despite already using strong treatments. Researchers will follow patients for 6 months after they switch to this medication to see if their asthma symptoms improve and how well they can stick with taking it.
Many people with severe asthma still struggle with symptoms even when taking multiple asthma medicines from separate inhalers. This medication combines three medicines into one inhaler to make treatment simpler and see if it helps more patients get better control of their asthma in real-world everyday life.
You likely qualify if…
You likely don't qualify if…
You will use the medication (two puffs twice daily) as prescribed by your doctor and visit the clinic at baseline and then 6 months later. At these visits, you will answer questions about your asthma symptoms, have your lung function tested, and discuss how well you are managing to take the medication as directed. The study simply tracks how you do on this treatment in your regular doctor's care—no extra experimental procedures are involved.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Slovenia